Enable Injections news

Enable Injections brings in $215M

Enable Injections has raised a $215 million Series C led by Magnetar Capital. The Cincinnati-based company is a developer of wearable drug delivery systems designed to administer high volumes of therapeutics.

Select Additional Investors

Jan. 30, 2022

Enable Injections shatters region`s previous fundraising record with $215M Series C

It’s another round for the record books. Enable Injections, an Evendale-headquartered medical device maker, today announced a $215 million Series C — again setting the pace for the highest fundraising round for a startup in the Greater Cincinnati region in a five-month span.

Enable, which is developing and manufacturing an investigational wearable drug delivery system called enFuse, said the growth capital injection will help it scale its development and commercializ

Jan. 26, 2022